Adenosquamous carcinoma of the lung is a rare and aggressive form of lung cancer that combines characteristics of two different cancer types, presenting unique diagnostic and treatment challenges for patients and medical teams alike.

What Is Adenosquamous Carcinoma of the Lung?

Adenosquamous carcinoma of the lung, often abbreviated as ASC, is a relatively uncommon form of lung cancer that falls under the broader category of non-small cell lung cancer, which refers to any type of epithelial lung cancer other than small cell lung cancer. What makes this cancer particularly distinctive is its dual nature: it contains components of both adenocarcinoma, which arises from mucus-producing cells, and squamous cell carcinoma, which develops from the flat cells lining the airways.^[1]

For a tumor to be classified as adenosquamous carcinoma, medical standards require that at least 10 percent of the tumor’s volume consists of each type—both adenocarcinoma and squamous cell carcinoma components must be present in significant amounts.^[2] This isn’t simply a matter of two cancers existing side by side; ASC represents a unique entity with its own biological characteristics and behavior patterns that differ from pure adenocarcinomas or squamous cell carcinomas alone.

Although ASC shares some biological traits with both adenocarcinoma and squamous cell carcinoma, it is not merely a simple combination of these two types. Instead, it behaves as its own distinct disease with specific patterns of growth and spread.^[1] This complexity makes ASC particularly challenging for both diagnosis and treatment planning.

Epidemiology

Adenosquamous carcinoma of the lung is quite rare compared to other lung cancer types. Studies indicate that ASC accounts for approximately 1.6 percent of all non-small cell lung cancer cases, making it an uncommon diagnosis that many physicians may encounter only occasionally in their practice.^[3]

Research examining demographic patterns shows that ASC affects both men and women, though the distribution varies across different studies. In one research cohort, the gender split showed 33 males and 25 females among ASC patients, suggesting a relatively balanced occurrence between sexes compared to some other lung cancer types that show stronger gender preferences.^[3]

The disease typically affects older adults, with studies reporting a mean age at diagnosis of around 70 years. In one large analysis of early-stage ASC patients, the average age was 70 years with a standard deviation of 9.5 years, indicating that most patients fall within the 60-80 age range at the time of diagnosis.^[6] This age distribution is consistent with lung cancer in general, as increasing age represents one of the most significant risk factors for developing any form of lung malignancy.

Due to its rarity, comprehensive global incidence data specifically for ASC remains limited. Most information comes from cancer registries in developed countries, particularly the United States, where detailed pathological classification allows for accurate identification of this specific subtype. The true global burden may be underestimated in regions where access to advanced diagnostic pathology is limited.

Causes

Like most forms of lung cancer, the exact mechanisms that cause cells to transform into adenosquamous carcinoma are not completely understood, but several important risk factors have been clearly identified. Understanding these causes helps patients and healthcare providers assess individual risk and potentially implement preventive strategies.

Smoking cigarettes stands out as the primary and most significant cause of adenosquamous carcinoma. The harmful chemicals in tobacco smoke damage the DNA in lung cells over many years, leading to mutations that can eventually result in cancer. The link between smoking and ASC is particularly strong—even more so than with some other lung cancer subtypes.^[4] Every cigarette contains thousands of chemicals, many of which are known carcinogens, meaning substances capable of causing cancer in living tissue.

Beyond active smoking, exposure to secondhand smoke also increases the risk of developing lung cancer, including ASC. People who live or work in environments where others smoke regularly inhale many of the same harmful chemicals, though in lower concentrations. Over time, this passive exposure accumulates and can contribute to cellular damage in the lungs.

Occupational exposure to certain substances represents another important cause of ASC. Workers who handle or breathe in asbestos fibers face increased risk, as these microscopic fibers lodge in lung tissue and cause chronic irritation and damage over decades. Other workplace carcinogens include radon gas, arsenic, chromium, beryllium, and nickel—substances found in various industrial settings from mining to manufacturing.^[4]

Previous radiation therapy, particularly to the chest area for other medical conditions, can also increase the likelihood of developing lung cancer years or even decades later. Additionally, having a family history of lung cancer may indicate genetic susceptibility that raises individual risk, though specific hereditary patterns for ASC have not been definitively established.^[4]

Risk Factors

Risk factors are characteristics, behaviors, or exposures that increase the likelihood of developing a disease. For adenosquamous carcinoma of the lung, several risk factors have been identified that overlap significantly with those for lung cancer in general, though some may carry particular relevance for this specific subtype.

Age represents the single most important risk factor for most cancers, including ASC. The risk of developing lung cancer increases substantially with advancing years, particularly after age 60. This reflects the accumulated exposure to various carcinogens over a lifetime and the natural aging process of cells, which can make them more susceptible to cancerous changes.

Current or former tobacco use dominates the risk profile for adenosquamous carcinoma. People who smoke cigarettes, pipes, or cigars face dramatically elevated risk compared to never-smokers. The risk increases with the number of cigarettes smoked per day and the total number of years someone has smoked. Even people who quit smoking many years ago carry elevated risk, though this risk does gradually decline over time after cessation.

Workplace exposures constitute another category of significant risk factors. Individuals working in industries involving asbestos, such as construction, shipbuilding, or automotive repair, face increased danger. Similarly, miners exposed to radon gas, workers handling arsenic or chromium compounds, and those in jobs with exposure to beryllium or nickel all carry higher risk for developing lung malignancies including ASC.^[4]

Environmental factors beyond the workplace also matter. People living in areas with high levels of air pollution may face increased risk. Residential radon exposure, which can occur in homes built over certain geological formations, represents a significant environmental hazard that many homeowners don’t realize affects them. Radon is a naturally occurring radioactive gas that seeps up from the ground and can accumulate in basements and lower floors of buildings.

Previous medical treatments involving radiation to the chest area increase lung cancer risk. This particularly affects survivors of breast cancer, lymphoma, or other conditions that required chest radiation as part of their treatment protocol. The cancer risk from radiation therapy typically doesn’t manifest until many years after treatment, sometimes decades later.^[4]

Having a family history of lung cancer may indicate genetic predisposition that elevates individual risk. While specific genes clearly linked to ASC haven’t been identified, familial clustering of lung cancer cases suggests that inherited factors play some role in susceptibility. This becomes particularly relevant for individuals with multiple close relatives affected by lung cancer.

Symptoms

The symptoms of adenosquamous carcinoma of the lung closely resemble those of other lung cancer types. In fact, symptoms alone cannot distinguish ASC from other forms of lung cancer—detailed pathological examination of tissue samples remains necessary for accurate diagnosis. Understanding these symptoms, however, helps patients recognize when to seek medical evaluation.

A persistent cough represents one of the most common early symptoms of ASC. Unlike the temporary cough that accompanies a cold or respiratory infection, lung cancer cough tends to linger for weeks or months without improvement. The cough may be dry or produce sputum, and it may worsen over time or change in character. Some patients notice their chronic “smoker’s cough” changes in quality or severity, which warrants medical attention.^[4]

Shortness of breath, medically termed dyspnea, occurs when tumors obstruct airways or when cancer affects the lung’s ability to exchange oxygen efficiently. Patients may notice they become winded more easily during activities they previously performed without difficulty. This breathlessness may gradually worsen, starting with limitations during strenuous activity and eventually affecting even simple tasks like walking short distances or climbing a single flight of stairs.^[4]

Chest pain associated with lung cancer can vary considerably in character and location. Some patients describe a dull, constant ache, while others experience sharp pains that worsen with deep breathing or coughing. The pain may localize to one area or spread across the chest. This occurs when tumors invade the chest wall, press on nerves, or cause inflammation of surrounding tissues.^[4]

Hemoptysis, the medical term for coughing up blood, represents a particularly alarming symptom that should always prompt immediate medical evaluation. The blood may appear as streaks in sputum, small clots, or larger amounts of bright red blood. Even small amounts of blood in sputum warrant investigation, as this symptom strongly suggests serious lung pathology requiring diagnosis.^[4]

Systemic symptoms affect the whole body rather than just the lungs. Unexplained weight loss occurs commonly with lung cancer, often because the cancer alters metabolism and suppresses appetite. Patients may lose significant weight without trying and despite maintaining normal eating habits. Fatigue or weakness that seems disproportionate to activity level also frequently accompanies lung cancer, leaving patients feeling exhausted even after adequate rest.^[4]

Recurrent respiratory infections like bronchitis or pneumonia may signal underlying lung cancer. When tumors partially obstruct airways, the areas of lung beyond the blockage become prone to infection because mucus and bacteria can’t clear properly. Patients who experience repeated bouts of pneumonia or bronchitis affecting the same area of lung should be evaluated for possible underlying malignancy.^[4]

Diagnosis

Diagnosing adenosquamous carcinoma presents significant challenges, and achieving an accurate diagnosis before surgery proves extremely difficult. The definitive diagnosis typically requires pathological examination of surgically resected tissue—meaning the most reliable way to identify ASC involves removing the tumor and examining it comprehensively under a microscope.^[1]

The diagnostic process usually begins with imaging studies when symptoms or screening raise suspicion for lung cancer. Chest X-rays may reveal abnormal masses or nodules, though they provide limited detail. Computed tomography scans, commonly called CT scans, offer much more detailed three-dimensional images of the lungs and can identify smaller tumors and their precise locations. These scans help determine the size of tumors, their relationship to surrounding structures, and whether cancer has spread to lymph nodes or other areas.^[4]

Bronchoscopy represents an important diagnostic procedure for lung cancer. During bronchoscopy, a thin, flexible tube with a camera is inserted through the nose or mouth and advanced into the airways. This allows direct visualization of the bronchi and enables physicians to obtain tissue samples from suspicious areas. The tissue samples, called biopsies, are then examined by pathologists who look for cancer cells and attempt to determine the specific type of lung cancer present.^[4]

Other biopsy methods may be employed depending on the tumor’s location. Needle aspiration involves inserting a thin needle through the chest wall into the tumor to withdraw cells for examination. This procedure, typically guided by CT imaging to ensure accurate needle placement, works well for tumors located in the outer portions of the lung. Surgical biopsy methods provide larger tissue samples and may be necessary when smaller biopsies yield inconclusive results.^[4]

The challenge with diagnosing ASC before surgery stems from the tumor’s heterogeneous nature. Small biopsy samples may capture only one component—either the adenocarcinoma or squamous cell areas—leading to initial classification as one of these pure types. Only when the entire tumor is removed and sectioned for comprehensive pathological examination can pathologists identify both components in sufficient proportions to confirm the ASC diagnosis.^[1]

Additional testing may include PET scans, which use radioactive tracers to identify metabolically active cancer cells throughout the body, helping determine whether cancer has spread beyond the lungs. Blood tests, while not diagnostic for lung cancer itself, help assess overall health and organ function, which becomes important for treatment planning.

Prevention

While not all cases of adenosquamous carcinoma can be prevented, several strategies significantly reduce risk. Prevention efforts focus on avoiding known carcinogens, making healthy lifestyle choices, and participating in screening programs when appropriate.

Not smoking—or quitting if you currently smoke—represents the single most powerful preventive measure against ASC and all lung cancers. People who never start smoking avoid the primary cause of lung cancer. For current smokers, quitting at any age reduces lung cancer risk, with risk continuing to decline the longer someone remains smoke-free. Numerous resources exist to support smoking cessation, including counseling programs, medications, nicotine replacement therapies, and support groups.

Avoiding secondhand smoke also contributes to prevention. This means not allowing smoking in homes or cars, choosing smoke-free establishments, and supporting smoke-free workplace policies. The cumulative effect of secondhand smoke exposure over years can substantially increase cancer risk, making these environmental choices important for protection.

Workplace safety measures protect people from occupational carcinogens. Employees working with asbestos, radon, or other hazardous materials should ensure their employers provide appropriate protective equipment and follow safety protocols. This includes wearing respirators or masks when exposure cannot be eliminated, maintaining proper ventilation, and following decontamination procedures. Workers should also take advantage of any health monitoring programs offered by employers in high-risk industries.

Testing homes for radon represents an important but often overlooked prevention strategy. Radon test kits are inexpensive and widely available. If testing reveals elevated radon levels, mitigation systems can reduce concentrations to safe levels, significantly lowering lung cancer risk for all household members. This becomes particularly important for homes built in areas known for higher radon levels.

Lung cancer screening provides another preventive opportunity, not by preventing cancer but by detecting it at earlier, more treatable stages. Current guidelines recommend annual screening with low-dose CT scans for people at high risk—generally defined as adults aged 50-80 who have a significant smoking history and currently smoke or have quit within the past 15 years. Early detection through screening can identify lung cancers when they’re smaller and haven’t spread, dramatically improving treatment outcomes and survival rates.

While no dietary supplements or specific foods have been proven to prevent lung cancer, maintaining overall good health through balanced nutrition, regular physical activity, and avoiding excessive alcohol consumption supports the immune system and may contribute to lower cancer risk as part of an overall healthy lifestyle.

Pathophysiology

Understanding how adenosquamous carcinoma develops and behaves in the body helps explain why this cancer acts differently from pure adenocarcinomas or squamous cell carcinomas. The pathophysiology refers to the functional changes that occur as the disease develops and progresses.

ASC arises from lung epithelial cells, which are the cells that line the airways and air sacs. Normal lung tissue contains different types of epithelial cells with distinct functions—some produce mucus, others are flat and protective, and still others facilitate gas exchange. In adenosquamous carcinoma, genetic mutations cause some of these cells to transform into cancer cells that display characteristics of two different cell types simultaneously.

The tumor contains distinct areas of adenocarcinoma, which originates from glandular cells that normally produce mucus, and areas of squamous cell carcinoma, which develops from the flat cells that typically line larger airways. These two components exist within the same tumor mass, sometimes intermixed and sometimes in separate regions. The precise proportion of each component can vary from tumor to tumor, though both must constitute at least 10 percent of the total tumor volume to meet diagnostic criteria.^[2]

Adenosquamous carcinomas typically originate in peripheral lung tissue rather than central airways, though they can occur anywhere in the lungs. As the tumor grows, it can invade surrounding lung tissue, blood vessels, and lymphatic channels. Lymphovascular invasion, which means cancer cells entering blood or lymph vessels, occurs commonly in ASC and facilitates the spread of cancer to lymph nodes and distant organs.^[5]

Research indicates that PD-L1, a protein that helps cancer cells evade the immune system, shows interesting expression patterns in ASC. Studies have found that PD-L1 expression tends to be higher in the squamous cell component compared to the adenocarcinoma component within the same tumor. This has important implications for treatment with immunotherapy drugs that target the PD-1/PD-L1 pathway.^[5][8]

At the molecular level, ASC can harbor various genetic mutations. Some tumors contain EGFR mutations, which are changes in the epidermal growth factor receptor gene that can be targeted with specific medications. Other possible mutations include changes in KRAS and ALK genes, though the frequency and significance of these alterations in ASC continue to be studied.^[5]

The aggressive nature of ASC manifests through its tendency for rapid growth and early spread compared to pure adenocarcinoma or squamous cell carcinoma. This biological aggressiveness translates to poorer prognosis, with studies consistently showing lower survival rates for ASC patients compared to those with pure forms of non-small cell lung cancer. Research has demonstrated that overall survival is significantly lower in ASC patients than in adenocarcinoma patients who undergo surgery during the same time period.^[3]

The tumor can affect lung function through multiple mechanisms. Large tumors may physically compress airways, restricting airflow and causing breathlessness. Cancer invasion into blood vessels can cause bleeding. Spread to the pleura, the membrane lining the lungs, can cause fluid accumulation called pleural effusion, which further compromises breathing. As the cancer progresses, it may spread to lymph nodes in the chest, and eventually to distant organs including the other lung, bones, brain, liver, and adrenal glands.